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ORIGINAL RESEARCH
Purpose: To determine whether q-space imaging (QSI), an advanced diffusion-weighted MRI method, provides a higher effect gradient 
to assess tumor cellularity than existing diffusion imaging methods, and fidelity to cellularity obtained from histologic analysis.
Materials and Methods: In this prospective study, diffusion-weighted images were acquired from 20 whole-breast tumors freshly excised 
from participants (age range, 35–78 years) by using a clinical 3.0-T MRI unit. Median and skewness values were extracted from the 
histogram distributions obtained from QSI, monoexponential model, diffusion kurtosis imaging (DKI), and stretched exponential 
model (SEM). The skewness from QSI and other diffusion models was compared by using paired t tests and relative effect gradient 
obtained from correlating skewness values.
Results: The skewness obtained from QSI (mean, 1.34 6 0.77 [standard deviation]) was significantly higher than the skewness from 
monoexponential fitting approach (mean, 1.09 6 0.67; P = .015), SEM (mean, 1.07 6 0.70; P = .014), and DKI (mean, 0.97 6 
0.63; P = .004). QSI yielded a higher effect gradient in skewness (percentage increase) compared with monoexponential fitting ap-
proach (0.26 of 0.74; 35.1%), SEM (0.26 of 0.74; 35.1%), and DKI (0.37 of 0.63; 58.7%). The skewness and median from QSI 
were significantly correlated with the skewness (r = −0.468; P = .038) and median (r = −0.513; P = .021) of cellularity from histologic 
analysis.
Conclusion: QSI yields a higher effect gradient in assessing breast tumor cellularity than existing diffusion methods, and fidelity to un-
derlying histologic structure.
Online supplemental material is available for this article.
Published under a CC BY 4.0 license.
Breast cancer is the most prevalent cancer in women (1), with neoadjuvant chemotherapy treatment used before 
surgery to downstage locally advanced breast tumors and 
facilitate conservation surgery (2,3). Although a complete 
pathologic response can be achieved for up to approxi-
mately 60% of patients with triple-negative and human 
epidermal growth receptor 2–positive breast cancers (4,5), 
a significant proportion of patients progress or show no 
response to treatment, leading to unnecessary exposure to 
drug toxicity and delay to surgical intervention. Patients 
who positively respond to neoadjuvant chemotherapy 
treatment show a reduction in tumor cellularity (the per-
centage of tissue composed of tumor cells), determined as a 
reduction in the proportion of viable tumor tissue in post-
treatment histologic analysis (6,7).
Diffusion-weighted imaging (DWI) is a conventional 
radiologic method that provides noninvasive assessment of 
cellularity by examining the extent that water self-diffusion 
is confined (8,9), with the proportion of viable tumor 
cellularity across whole tumors inferred as the amount of 
skewness present in histogram distributions (10). How-
ever, DWI has limited clinical application because of a 
low measurement-effect gradient and in turn sensitivity 
to treatment effectiveness (11–13). Whereas the mono-
exponential fitting approach reduces the susceptibility of 
DWI to acquisition configuration (14), the diffusion kur-
tosis imaging (DKI) (15) and stretched exponential model 
(SEM) (16) fitting approaches account for the complexity 
of diffusion in tissue, providing a more accurate represen-
tation of diffusion in breast carcinoma (17). However, the 
diffusion measurements obtained from these approaches 
come from idealistic models of diffusion and are unspecific 
to underlying tissue features (18).
q-Space imaging (QSI) eliminates the constraints intro-
duced by modeling approaches, with measurements made 
directly from the diffusion pattern providing microstructure 
quantification in the brain (19,20) and sensitive assessment 
of the changes that arise from malignant transformation 
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Figure 1: Study design. The study design adopted for evaluating q-space imaging (QSI) versus other diffusion-
weighted imaging (DWI) techniques for the assessment of tumor cellularity in breast cancer application is shown. Dif-
fusion acquisition 1 was analyzed by using fitting methods (monoexponential model [MONO], stretched exponential 
model [SEM], and diffusion kurtosis imaging [DKI]) at DWI to obtain respective measurements of diffusivity. Diffusion 
acquisition 2 was analyzed by using QSI to obtain the full width half maximum  (FWHM) of the probability density 
function. Of the 28 tumors imaged in this study, eight were excluded due to the exclusion criteria of diameter < 15 mm, 
lobular phenotype, and tumor grading criteria, as reported in the final pathology. Tumor skewness was quantified from 
the histogram distributions obtained from the DWI methods and cellularity.
the 32 participants approached, all participants consented to 
the study and 28 specimens were imaged because of scanner 
availability. Twenty female participants (mean age, 57 years; 
age range, 35–78 years; 10 participants with grade II and 10 
participants with grade III carcinoma) met the inclusion crite-
ria on the basis of final histologic analysis (Table 1).
Tumor Inclusion
The excised whole tumor was placed in a sealed container filled 
with 10% formalin solution and immobilized by using a spe-
cially designed holding harness before overnight imaging for 
no delay to routine reporting. After histopathologic examina-
tion of the excised tumor, tumors with final diagnosis of lobu-
lar phenotype, tumor diameter less than 15 mm at histologic 
analysis, tumor downgraded to grade I, and tumors in excess 
of the grade III recruitment allocation were excluded (Fig 1).
Image Acquisition
Images were acquired on a clinical 3.0-T MRI unit with 
maximum gradient strength of 80 mT/m (Achieva Tx; Phil-
ips Healthcare) by using a body coil for uniform transmis-
sion and a 32-channel receiver head coil for high sensitivity 
signal detection. All imaging volumes were centered on the 
tumor with sections on the horizontal plane and circular 
saturation bands positioned around the tumor to suppress 
the signal from formalin. Anatomic images were acquired by 
using a standard T1-weighted three-dimensional sequence 
(23) as follows: repetition time (TR) msec/echo time (TE)
(21). QSI has been shown to be feasible on clinical MRI units 
because of recent hardware advances meeting the demand on 
magnetic field gradient, with application demonstrated in brain 
malignancies (22). We therefore hypothesized that measurements 
of breast tumor cellularity obtained with QSI have a higher effect 
gradient compared with other existing DWI techniques, and fidel-
ity to the cellularity obtained from histologic analysis.
Materials and Methods
To test the study hypothesis, we con-
ducted a prospective study in partici-
pants with breast cancer on a clinical 
MRI unit by using a series of DWI 
examinations performed on whole 
tumors freshly excised from partici-
pants. Participants were enrolled con-
secutively from Aberdeen Royal Infir-
mary (Aberdeen, Scotland) between 
August 2016 and June 2017 (Fig 1). 
The study was approved by the North 
West–Greater Manchester East Re-
search Ethics Committee (identifier: 
16/NW/0221) and signed written 
informed consent was obtained from 
the participants prior to entry into the 
study. Authors had control of data and 
information submitted for publication. 
Philips Healthcare (Best, the Nether-
lands) is acknowledged in this study 
for providing clinical scientist support.
Participant Eligibility
Participants with grade II or III inva-
sive carcinoma, tumor diameter greater 
than 15 mm, undergoing breast con-
servation surgery, with no chemo-
therapy or radiation therapy treatment 
before surgery were eligible. Among 
Abbreviations
DKI = diffusion kurtosis imaging, DWI = diffusion-weighted imaging, 
FWHM = full width at half maximum, QSI = q-space imaging, SEM 
= stretched exponential model, TE = echo time, TR = repetition time
Summary
q-Space imaging yields a higher effect gradient to assess cellularity 
in breast cancer compared with conventional diffusion-weighted 
imaging methods by using a clinical 3.0-T MRI unit to image 
whole freshly excised breast tumors.
Key Points
 n The degree of tumor skewness obtained from q-space imaging 
(1.34 ± 0.77) was significantly higher than that obtained from 
existing diffusion imaging methods, and yielded a higher relative 
effect gradient. 
 n The median and skewness from q-space imaging were significantly 
correlated with the median (r = −0.513, P = .021) and skewness (r 
= −0.468, P = .038) of cellularity from histologic analysis.
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sec/mm2, as follows: d/, 24.9/37.8 msec; TR/TE, 5900/94 
msec; one signal average; and duration, 47:59 minutes.
Image Analysis
To remove directionality, images of a specific diffusion weight-
ing were computed as the voxel-wise average of images from 
three orthogonal diffusion directions of the corresponding 
diffusion weighting. Images were analyzed by using in-house 
software written in Matlab (MathWorks, Natick, Mass). Im-
ages from all diffusion acquisitions were convolved with a 
Gaussian kernel with full width at half maximum (FWHM) 
of 3 mm within the plane to reduce noise level in accordance 
with standard diffusion image analysis procedures (24). Sub-
sequently, the diffusivity maps of DWI were computed from 
conventional DWI by using a voxel-wise standard logarithmic 
algorithm (23). The diffusivity maps of monoexponential fit-
ting approach, DKI, and SEM were computed from diffusion 
acquisition 1 by using a nonlinear fitting algorithm (15–17).
QSI analysis was performed voxel-wise by using fast Fou-
rier transform to compute the displacement probability density 
function from diffusion acquisition 2 (19). Diffusion-weighted 
msec, 5.7/2.9; field of view, 141 3 141 mm2; 256 3 256 
matrix; 28 sections; section thickness, 1.1 mm; and parallel 
acquisition acceleration factor, 1.5. Diffusion examinations 
were performed by using a multishot pulsed gradient spin-
echo sequence (23) as follows: field of view, 141 3 141 mm2; 
section thickness, 2.2 mm; 64 3 64 matrix; in-plane resolu-
tion, 2.2 3 2.2 mm2; and seven to 10 sections depending 
on tumor size. Conventional DWI acquisition (for tumor 
delineation) was performed over two diffusion-weighted 
sequences (ie, b values) of 0 and 800 sec/mm2, as follows: 
diffusion time (d/), 15.3/27.5 msec; TR/TE, 3000/70 
msec; one signal average; and duration, 2:21 minutes. The 
first diffusion imaging acquisition, or diffusion acquisition 
1 (for monoexponential fitting approach, DKI, and SEM 
assessment), was performed over 17 linearly spaced b values 
from 0 to 2400 sec/mm2, as follows: spacing, 150 sec/mm2; 
d/, 18.7/31.5 msec; TR/TE, 3100/82 msec; two signal av-
erages; and duration, 25:28 minutes. The second diffusion 
imaging acquisition, or diffusion acquisition 2 (for QSI as-
sessment), was performed over 32 equidistant q values from 
10.4 to 655 cm−1, equivalent to a maximum b value of 5000 
Table 1: Tumor Characteristics
Tumor Type With DCIS
Tumor Size 
(mm) Grade ER PR HER2
Invasive mucinous carcinoma No 23 2 + + −
Invasive carcinoma NST Yes 24 3 − + −
Invasive carcinoma NST Yes 32 3 − − −
Invasive carcinoma NST Yes 31 3 − − −
Invasive carcinoma NST Yes 35 2 + − −
Invasive carcinoma NST No 22 3 + + +
Invasive carcinoma NST* Yes 29 3 − − −
Invasive carcinoma NST Yes 23 2 + + −
Invasive carcinoma NST No 22 3 + + −
Invasive carcinoma NST Yes 30 3 + + +
Invasive carcinoma NST Yes 28 3 + + −
Invasive carcinoma NST Yes 24 3 + + −
Invasive carcinoma NST Yes 32 3 + + +
Invasive carcinoma NST Yes 25 2 + + −
Invasive mixed carcinoma NST with 
cribriform carcinoma
Yes 26 2 + + +
Invasive carcinoma NST Yes 20 2 + + −
Invasive carcinoma NST† Yes 18 2 + − −
Invasive carcinoma NST Yes 18.5 2 + + −
Invasive carcinoma NST No 39 2 + + −
Invasive carcinoma NST‡ No 27 2 + + −
Note.—The tumor characteristics of each invasive carcinoma breast tumor are shown. Invasive lobular carcinoma 
types were not included in the study. With DCIS refers to the presence of ductal carcinoma in situ. Tumor size 
refers to the maximum diameter of tumor. There were three invasive carcinoma of no special type that showed 
less than 50% of special type tumor morphologic structure. + = positive, − = negative, DCIS = ductal carcinoma 
in situ, ER = estrogen receptor, HER2 = human epidermal growth factor receptor 2, NST = no special type, PR = 
progesterone receptor.
* Carcinoma with apocrine features.
† Carcinoma with lobular features. 
‡ Carcinoma with cribriform features.
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skewness values from each diffusion method were correlated 
against the skewness values from QSI. The relative effect gradi-
ent was evaluated as the line of best fit gradient and reported 
as percentage increase. The correspondence of the median and 
skewness between diffusion imaging techniques and the under-
lying cellularity were examined by using Spearman correlation. 
In addition, to examine whether QSI analysis was feasible for 
a reduced sampling density, the correspondence between the 
skewness and median values obtained from QSI analysis at 11 
and 32 q values was examined by using Pearson correlation.
Results
Individual tumor characteristics of all 20 invasive carcinoma 
specimens including tumor type, size, and hormone receptor 
status are in Table 1.
There was significant difference in skewness obtained from 
diffusion methods (F = 4.803; P = .015). The skewness from 
QSI (cohort mean, 1.34 6 0.77 [standard deviation]) was sig-
nificantly higher (P < .017) compared with the skewness from 
monoexponential fitting approach (1.09 6 0.67; P = .015), 
SEM (1.07 6 0.70; P = .014), and DKI (0.97 6 0.63; P = .004) 
(Table 2, Fig 2). There was significant (P , .0005) linear correla-
tion between the skewness from QSI and other diffusion meth-
ods, with QSI yielding a higher relative effect gradient (percent-
age increase) compared with monoexponential fitting approach, 
0.26 of 0.75 (35.1%); SEM, 0.26 of 0.75 (35.1%); and DKI, 
0.37 of 0.63 (58.7%) (Table 2, Fig 3).
There was a significant (P ,.05) correlation between the 
skewness from cellularity and the skewness from QSI (r = 
−0.468; P = .038) and DKI (r = −0.541; P = .014) (Table 2, 
Fig 4). However, there was nonsignificant correlation between 
the skewness from cellularity and skewness from monoexpo-
nential fitting approach (r = −0.433; P = .056) and SEM (r 
= −0.389; P = .090). There was significant (P ,.05) negative 
correlation between the median of cellularity and the medi-
ans from QSI, monoexponential fitting approach, SEM, and 
DKI (Table 2, Fig 4).
There was a significant correlation between the median and 
skewness from downsampled QSI and fully sampled QSI (Fig 
E2 [supplement]).
Discussion
We found that the tumor cellularity obtained from QSI had an 
increased effect gradient compared with the other DWI tech-
niques, providing a measurement with amplified skewness in 
the tumor histogram distribution and significant correlation to 
the cellularity skewness from histologic analysis.
The significantly higher values of skewness obtained from 
QSI corresponded to an increased measurement effect gradi-
ent and hence higher sensitivity to the underlying differences 
in breast tumors. With a positive response to treatment, there 
is a reduction in the amount of tumor cellularity, which cor-
responds to a reduced proportion of viable tumor tissue (6). 
The loss of cellularity is observed as a characteristic shift in 
the histogram distribution to higher diffusivity values and 
reduced skewness as the tumor composition becomes more 
signal was mirrored around a q value of 0 cm−1 before fast Fourier 
transform (20). The FWHM was obtained from the resulting 
distribution, quantifying the extent of diffusion (25). To evalu-
ate the dependence of QSI on sampling density, the analysis was 
repeated for a downsampled 11 q values from diffusion acquisi-
tion 2, linearly spaced from 30.1 to 655 cm−1.
Regions of interest were drawn by a single operator in MRI-
cron (University of South Carolina, Columbia, South Carolina, 
https://people.cas.sc.edu/rorden/mricron/index.html) on DWI dif-
fusivity maps to delineate the entire tumor mass from surround-
ing breast tissue (26). Voxels within the tumor core from the dif-
fusivity map from each diffusion method (FWHM map in the 
case of QSI) were subsequently extracted to form a histogram 
for each tumor. The median and skewness were then computed 
from the histogram distribution as the markers of average and 
asymmetry of histogram distribution, respectively, for the cor-
responding diffusion method (11,12,27).
Histopathologic Analysis
Routine histologic assessment was performed to obtain the 
phenotype classification, tumor diameter, and grading on the 
basis of the Nottingham Grading System (28). From each tu-
mor, a representative hematoxylin-eosin–stained section was 
digitally imaged at a pixel size of 0.505 mm on a slide scan-
ner (Aperio CS2; Leica Biosystems, Melbourne, Australia). 
The regions of the images covering the tumor area were then 
fragmented into image tiles of 800 3 800 pixels (0.16 mm2; 
Fig E1 [supplement]). A total of 94 tiles among the overall 
19 547 tiles from the participants were excluded because of 
inadequate staining quality or mounting artifact during slide 
scanning. Images were processed by using software (ImageJ; 
National Institutes of Health, Bethesda, Md) to obtain binary 
masks of stained nuclei material, with an intensity threshold 
applied to the red channel image (8,9,14). The cellularity of an 
image tile was computed as the ratio between the image mask 
positive for nuclei material and the tile size (8, 9, 21). Median 
and skewness values were extracted from cellularity histogram 
distributions compiled from all the image tiles within each tu-
mor section.
Statistical Analysis
Statistical analysis was performed by using software (SPSS 
version 24.0; IBM, Armonk, NY). All cohort distributions of 
skewness and median values were confirmed to be normally 
distributed by using the Shapiro-Wilk method. Note that this 
may be a result of underpowering because with a small sample 
virtually all distributions are indistinguishable from normal. 
Any overall differences in mean values of skewness between 
diffusion imaging methods was examined by using within-
subjects analysis of variance. Post hoc paired t test comparison 
was used to investigate whether there was a significant dif-
ference between the skewness values obtained from QSI and 
other diffusion methods by applying Bonferroni correction 
for multiple comparisons for a significance level of P less than 
.017. To investigate whether QSI yields a higher relative ef-
fect gradient compared with existing diffusion methods, the 
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identification of nonresponding participants (11–13,30). We 
find QSI to increase the effect gradient of skewness assess-
ments, and therefore potentially it provides a marker with im-
proved sensitivity in detecting the changes to tumor cellularity 
that occur with a positive early response to treatment.
Our results show QSI to provide sensitive noninvasive assess-
ment of breast tumor cellularity, in agreement with results from 
in vivo imaging of meningioma (22) and preclinical imaging 
of excised esophageal carcinoma samples (21). Previous studies 
have demonstrated an inverse correlation between the cellular-
ity of breast tumors and the average diffusivity obtained at con-
ventional DWI (8,9), whereas others have shown nonsignificant 
correlation and limited specificity (31). In our study, we found 
a significant inverse correlation between the median cellularity 
and median values from all DWI techniques that is consistent 
with a previously reported pooled strength of association (r = 
−0.48) from conventional diffusion imaging of breast cancer 
(32). Tumor heterogeneity was accounted for by taking the aver-
age as the median value from the corresponding histogram dis-
tributions (33). A comprehensive assessment of average tumor 
cellularity was obtained from histologic analysis of whole slide 
sections. Histogram distributions of cellularity did not distin-
guish between malignant and nonmalignant cells. Although not 
investigated in this study, a large amount of tumor-infiltrating 
immune cells may influence the associations measured between 
diffusion properties and cellularity.
The skewness from QSI and DKI, compared with mono-
exponential fitting approach and SEM, showed significant 
homogeneous (11–13). Changes to skewness have been shown 
to precede changes to the texture and width of histograms in 
chemotherapy and radiation therapy treatment of advanced 
cervical cancers by using conventional DWI (29). Whereas 
previous studies have shown the added sensitivity of the use of 
skewness in detecting response at DWI (10) and dynamic con-
trast agent–enhanced imaging (30), the low percentage change 
in skewness relative to its high measurement error prevents 
Table 2: Comparison of Diffusion-weighted Imaging Techniques
Parameter
Mean of the 
Median
Median Correlation 
to Cellularity Skewness
Skewness 
Correlation to 
Cellularity Skewness Correlation to QSI
r  
Value 
P  
Value Mean t Score 
P  
Value
r  
Value
P  
Value R Value P Value Gradient Intercept
QSI (mm) 11.3 6  
0.72
−0.513 .021 1.34 6  
0.77
−0.468 .038
MONO  
(10−3  mm2 
sec−1)
0.40 6  
0.10
−0.568 .009 1.09 6  
0.67
−2.686 .015 −0.433 .056 0.846 ,.0005 0.74 0.10
SEM  
(10−3  mm2 
sec−1)
0.40 6  
0.12
−0.570 .009 1.07 6  
0.70
−2.711 .014 −0.389 .090 0.817 ,.0005 0.74 0.08
DKI (10−3  mm2 
sec−1)
0.55 6  
0.16
−0.510 .022 0.97 6  
0.63
−3.314 .004  −0.541 .014 0.771 ,.0005 0.63 0.13
Cellularity (%) 17.2 6  
5.8
−0.20 6 
0.51
Note.—Mean data are 6 standard deviation. For each diffusion-weighted imaging technique, the cohort mean of the median and skew-
ness of diffusivity is shown for the monoexponential model (MONO), stretched exponential model (SEM) and diffusion kurtosis imaging 
(DKI), and full width at half maximum for q-space imaging (QSI). The cohort mean of the median and skewness of cellularity is shown. 
The skewness obtained from each method compared against the skewness from QSI by paired sample t test is shown, with associated t score 
(t) and P value. The skewness obtained from each method compared against the skewness from QSI by Pearson correlation is shown, with 
associated Pearson correlation coefficient (R), P value, along with the gradient (relative measurement effect gradient) and intercept of the 
line of best fit. The median and skewness obtained from each diffusion method compared against that from cellularity by Spearman correla-
tion is shown, with associated Spearman correlation coefficient (r) and P value.
Figure 2: Plot shows comparison of skewness of diffusion-
weighted imaging techniques. The skewness from diffusivity 
obtained from each of the diffusion-weighted imaging techniques 
(the monoexponential model [MONO], stretched exponential 
model [SEM],and diffusion kurtosis imaging [DKI]) is shown and 
compared with the skewness obtained from q-space imaging 
(QSI) full width at half maximum. Each dot represents a single 
tumor value and the error bar represents the cohort mean 6 stan-
dard deviation.
6 radiology-ic.rsna.org n Radiology: Imaging Cancer Volume 1: Number 1—2019
q-Space Imaging to Assess Cellularity
inverse correlation with the skewness in 
cellularity, with QSI providing both fi-
delity to the underlying tumor histologic 
structure and the highest relative effect 
gradient. Therefore, QSI is a promis-
ing approach to noninvasively monitor 
changes in cellularity occurring with posi-
tive treatment response, where core biopsy 
can only provide partial sampling of cel-
lularity and is incapable of assessing the 
whole tumor (34).
This study addresses the urgent clinical 
need to amplify the sensitivity of nonin-
vasive cellularity markers through com-
prehensively evaluating QSI translated 
for clinical research on a 3.0-T MRI unit. 
This study investigated the sensitivity of 
QSI compared with existing radiologic 
methods in 20 large tumors of invasive 
carcinoma. Tumor cellularity was ob-
tained from imaging whole-breast tumors freshly excised from 
participants and before routine histologic analysis, where pre-
vious studies have been limited to imaging smaller sections of 
tumor tissue that are surplus to the amount of tumor tissue 
required for histologic reporting (18,21). We demonstrate the 
pertinence of QSI to provide sensitive assessment of tumor cel-
lularity and to be feasible by using a downsampled number of 
diffusion weightings for clinical breast imaging durations.
Our study had limitations. Because this study was limited 
to a cohort of 20 participants, narrow inclusion criteria were 
imposed on phenotype and tumor size to ensure statistical 
power for the comparison of effect gradient at an effect size 
clinically relevant for personalized care. The study was limited 
to grade II or III invasive carcinomas with large tumor size, 
excluding lobular type and grade I tumors because invasive 
ductal carcinomas are the most commonly diagnosed type 
of breast cancer (35). To meet the clinical requirements of 
routine histologic analysis following the imaging study, buff-
ered 10% formalin solution was added to the freshly excised 
breast tissue before imaging overnight on the same day as 
excision. Although tissue fixation affects diffusion measure-
ments, tumors were imaged before fixation, with formalin 
penetration into tissue typically at 1 mm per hour followed 
by an additional 24 hours for the tumor to become fixed 
(36,37), allowing whole tumors to be imaged at the point 
of excision rather than cut sections of tissue surplus to rou-
tine histologic analysis. Tumors were further monitored for 
experimental stability by an additional three repeated DWI 
acquisitions to encompass the diffusion acquisitions, and no 
significant difference in median or skewness from diffusiv-
ity was found (data not shown). A 32-channel head receiver 
coil was used so that excised tumors could be placed at the 
isocenter of the imager to allow power calibration and shim-
ming functions by using a clinical MRI unit. Translation of 
Figure 3: Graphs show correlation of skewness. The skewness of diffusivity obtained from, A, monoexponential model (MONO), B, stretched exponential model 
(SEM), and, C, diffusion kurtosis imaging (DKI) is plotted against the skewness obtained from q-space imaging (QSI) full width at half maximum. The line of best fit is shown, 
with each dot representing a single tumor value. The relative effect gradient was determined from the line of best fit gradient for skewness values. QSI yielded a higher rela-
tive effect gradient (percentage increase) compared with MONO (0.26 of 0.75; 35.1%), SEM (0.26 of 0.75; 35.1%), and DKI (0.37 of 0.63; 58.7%).
Figure 4: Scatterplot shows correlation between q-space imaging (QSI) and cellularity. The correspon-
dence of the median and skewness between diffusion imaging techniques and the underlying cellularity were 
examined using Spearman correlation. A, Correlation between the skewness obtained from QSI plotted against 
the skewness of cellularity. B, Correlation between the medians from QSI and cellularity. Each dot represents a 
single tumor value.
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QSI into the clinic requires optimization to ensure adequate 
signal-to-noise ratio, through adjustment of voxel size, imag-
ing duration, and receiver coil choice.
Future in vivo studies should investigate the reproducibil-
ity of QSI markers and association to a wider range of tumor 
sites, phenotypes, and treatments. The inclusion of additional 
markers of histogram shape and texture may also offer comple-
mentary information to radiomics analysis (38), diagnostic dis-
crimination of lesion malignancy (39), and existing formal his-
topathologic classifications (34) to include clinically relevant 
information for the pretreatment tumor status and extent of 
residual disease.
In conclusion, QSI had increased effect gradient com-
pared with monoexponential fitting approach, SEM, and 
DKI diffusion imaging techniques for evaluating whole-
breast tumor cellularity, and yielded fidelity to the underly-
ing tumor histologic structure. QSI provides a promising 
noninvasive approach to elucidate cellularity in whole-
breast tumors at 3.0 T.
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